多潘立酮和莫沙必利治疗急性脑梗死并消化道症状的疗效比较  

A Comparison of therapeutic effects of mosapride versus demperidone on patients with digestive symptoms induced by acute brain infarction

作　　者：尤华强[1] 孙金栋[1] 张秋凤[1] 

机构地区：[1]杭州师范学院医学院附属余杭医院,浙江杭州311100

出　　处：《杭州医学高等专科学校学报》2004年第2期62-63,共2页Journal of Hangzhou Medical College

摘　　要：目的　比较多潘立酮和莫沙必利治疗急性脑梗死并消化道症状的疗效。方法　将急性脑梗死并消化道症状患者 70例 ,随机分为莫沙必利组 35例和多潘立酮组 35例 ,治疗 2周。结果　莫沙必利组在急性脑梗死所并发的各消化道症状的总有效率上 ,均优于多潘立酮组。结论　莫沙必利治疗急性脑梗死所并发的消化道症状疗效显著 ,安全性高 ,值得临床推广应用。Objective To compare the clinical effects between mosapride and demperidone on digestive symptoms induced by acute brain infarction. Methods 70 patients with digestive symptoms induced by acute brain infarction were randomly divided into two groups and treated for 2 weeks with either mosapride 5mg tid(\%n\%=35) or demperidone 10mg tid(\%n\%=35).Results The total effective rates of mosapride were higher than those of demperidone in treating various digestive symptoms induced by acute brain infarction.Conclusion Mosapride had significant effects on digestive symptoms induced by acute brain infarction, it was very safe and worth clinical application.

关 键 词：急性脑梗死 消化道症状 莫沙必利 多潘立酮 

分 类 号：R743.33[医药卫生—神经病学与精神病学]